跳转至内容
Merck
CN

387A

白细胞酸性磷酸酶(TRAP)试剂盒

Kit formulated with all liquid reagents

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
12352106
NACRES:
NA.47
eCl@ss:
42010102
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

Quality Level

shelf life

Expiry date on the label.

IVD

for in vitro diagnostic use

dilution

(for histology)

application(s)

hematology
histology

shipped in

wet ice

storage temp.

2-8°C

正在寻找类似产品? 访问 产品对比指南

Biochem/physiol Actions

外周血或骨髓制剂被固定在显微镜载玻片上。将所得薄膜在萘酚AS-BI 磷酸溶液和新鲜重氮化的 Fast Garnet GBC 溶液中培养。 该试剂盒用于显示血液、骨髓和组织接触制剂中的酸性磷酸酶和抗酒石酸酸性磷酸酶 (TRAP)。

仅试剂盒组分

产品编号
说明

  • Hematoxylin Solution, Gill No. 3 (kit only) 50 mL

试剂盒组分也可单独购买

产品编号
说明
化学品安全说明书

  • 3863Acetate Solution, 2.5 M, pH 5.2 50 mL化学品安全说明书

  • 915Citrate Solution, pH 3.6±0.1 (25 °C), 27 mM 50 mL化学品安全说明书

  • 3872Fast Garnet GBC Base Solution 10 mL化学品安全说明书

  • 3871Naphthol AS-BI Phosphoric Acid Solution 10 mL化学品安全说明书

  • 914Sodium nitrite solution 10 mL化学品安全说明书

  • 3873Tartrate Solution 10 mL化学品安全说明书

signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Carc. 1B - Eye Dam. 1 - Met. Corr. 1 - Skin Corr. 1B - STOT RE 2 Oral

target_organs

Kidney

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

法规信息

监管及禁止进口产品

此项目有


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Huey-En Tzeng et al.
Scientific reports, 8(1), 11190-11190 (2018-07-27)
NC-8 (ent-16-oxobeyeran-19-N-methylureido) is an isosteviol-derived analogue with multiple biological effects, including anti-inflammation and anti-bacterial activities and inhibition of HBV viral surface antigen gene expression. In this study, we explored the effects of NC-8 on the formation of osteoclasts from RAW
Yun Zhang et al.
Biological & pharmaceutical bulletin, 39(12), 2028-2035 (2016-12-03)
Osteolysis induced by chronic Gram-negative bacterial infection underlies many bone diseases such as osteomyelitis, septic arthritis, and periodontitis. Drugs that inhibit lipopolysaccharide (LPS)-induced osteolysis are critically needed for the prevention of bone destruction in infective bone diseases. In this study
L Wei et al.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 25(8), 2089-2096 (2014-05-09)
Recently, the use of the pharmacological agent strontium ranelate has come to prominence for the treatment of osteoporosis. While much investigation is focused on preventing disease progression, here we fabricate strontium-containing scaffolds and show that they enhance bone defect healing
Jihai Wang et al.
Frontiers in pharmacology, 9, 64-64 (2018-02-24)
Lipopolysaccharide (LPS) can induce bone loss by stimulating bone resorption. Natural compounds have great potential for the treatment of osteolytic bone diseases. Magnesium lithospermate B (MLB) plays an important role in protecting against oxidative damage and also has potential anti-inflammatory
Rafael Pacheco-Costa et al.
Bone, 114, 22-31 (2018-06-08)
Aging is accompanied by imbalanced bone remodeling, elevated osteocyte apoptosis, and decreased bone mass and mechanical properties; and improved pharmacologic approaches to counteract bone deterioration with aging are needed. We examined herein the effect of mefloquine, a drug used to

全球贸易项目编号

货号GTIN
387A-1KT04061831967975

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持